Literature DB >> 19261599

Germline mutation in DOK7 associated with fetal akinesia deformation sequence.

J Vogt1, N V Morgan, T Marton, S Maxwell, B J Harrison, D Beeson, E R Maher.   

Abstract

BACKGROUND: Fetal akinesia deformation sequence syndrome (FADS) is a heterogeneous disorder characterised by fetal akinesia and developmental defects including, in some case, pterygia. Multiple pterygium syndromes (MPS) are traditionally divided into prenatally lethal and non-lethal (such as Escobar) types. Previously, we and others reported that homozygous mutations in the fetal acetylcholine receptor gamma subunit (CHRNG) can cause both lethal and non-lethal MPS, demonstrating that pterygia resulted from fetal akinesia, and that mutations in the acetylcholine receptor subunits CHRNA1, CHRND, and Rapsyn (RAPSN) can also result in a MPS/FADS phenotype.
METHODS: We hypothesised that mutations in other acetylcholine receptor related genes may interfere with neurotransmission at the neuromuscular junction and so we analysed 14 cases of lethal MPS/FADS without CHRNG, CHRNA1, CHRNB1, CHRND, or RAPSN mutations for mutations in DOK7.
RESULTS: A homozygous DOK7 splice site mutation, c.331+1G>T, was identified in a family with three children affected with lethal FADS. Previously DOK7 mutations have been reported to underlie a congenital myaesthenic syndrome with a characteristic "limb girdle" pattern of muscle weakness.
CONCLUSION: This finding is consistent with the hypothesis that whereas incomplete loss of DOK7 function may cause congenital myasthenia, more severe loss of function can result in a lethal fetal akinesia phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261599     DOI: 10.1136/jmg.2008.065425

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.

Authors:  D Lashley; J Palace; S Jayawant; S Robb; D Beeson
Journal:  Neurology       Date:  2010-05-11       Impact factor: 9.910

2.  Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L.

Authors:  Peter T Hallock; Chong-Feng Xu; Tae-Ju Park; Thomas A Neubert; Tom Curran; Steven J Burden
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

3.  Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.

Authors:  Marshall Lukacs; Jonathan Gilley; Yi Zhu; Giuseppe Orsomando; Carlo Angeletti; Jiaqi Liu; Xiuna Yang; Joun Park; Robert J Hopkin; Michael P Coleman; R Grace Zhai; Rolf W Stottmann
Journal:  Exp Neurol       Date:  2019-05-25       Impact factor: 5.330

4.  Neuromotor synapses in Escobar syndrome.

Authors:  Karyn G Robinson; Matthew J Viereck; Megan V Margiotta; Karen W Gripp; Omar A Abdul-Rahman; Robert E Akins
Journal:  Am J Med Genet A       Date:  2013-08-16       Impact factor: 2.802

5.  Autosomal-Dominant Multiple Pterygium Syndrome Is Caused by Mutations in MYH3.

Authors:  Jessica X Chong; Lindsay C Burrage; Anita E Beck; Colby T Marvin; Margaret J McMillin; Kathryn M Shively; Tanya M Harrell; Kati J Buckingham; Carlos A Bacino; Mahim Jain; Yasemin Alanay; Susan A Berry; John C Carey; Richard A Gibbs; Brendan H Lee; Deborah Krakow; Jay Shendure; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2015-05-07       Impact factor: 11.025

Review 6.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

7.  Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).

Authors:  Esther Meyer; Christopher Ricketts; Neil V Morgan; Mark R Morris; Shanaz Pasha; Louise J Tee; Fatimah Rahman; Anne Bazin; Bettina Bessières; Pierre Déchelotte; Mohamed T Yacoubi; Mudher Al-Adnani; Tamas Marton; David Tannahill; Richard C Trembath; Catherine Fallet-Bianco; Phillip Cox; Denise Williams; Eamonn R Maher
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

Review 8.  Congenital myasthenic syndromes in 2012.

Authors:  Andrew G Engel
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

9.  Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7.

Authors:  A Ben Ammar; F Petit; N Alexandri; K Gaudon; S Bauché; A Rouche; D Gras; E Fournier; J Koenig; T Stojkovic; A Lacour; P Petiot; F Zagnoli; L Viollet; N Pellegrini; D Orlikowski; L Lazaro; X Ferrer; G Stoltenburg; M Paturneau-Jouas; F Hentati; M Fardeau; D Sternberg; D Hantaï; P Richard; B Eymard
Journal:  J Neurol       Date:  2009-12-11       Impact factor: 4.849

Review 10.  Congenital Myasthenic Syndromes in 2018.

Authors:  Andrew G Engel
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-12       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.